Expert Discussion | The Future of Heart Valve Treatment
How new treatment approaches can enable people with heart valve disease to live without repeated procedures and long-term medication
Dr. med. Boris Schmitt, Boris Warnack
Thursday, 16 April 2026
17:00 - 18:00 CEST
Limited number of seats: 13 / 25
About the event
What if heart valves only needed to be replaced once?
Every year, around 1.4 million children are born with heart defects. For many of those affected, this means repeated operations, implants with a limited lifespan and lifelong medication. Despite medical advances, existing treatments are reaching their limits in this area.
But this is precisely where a new generation of heart valve treatment comes in.
In the expert discussion, Boris Schmitt (founder of GrOwnValve) and Boris Warnack (CTO of GrOwnValve) will discuss an innovative approach: personalised heart valves that can be manufactured directly in the operating theatre from the patient’s own tissue and implanted using minimally invasive techniques.
No foreign tissue. No external production. With the aim of avoiding repeat procedures in the long term and sustainably improving quality of life.
What to expect in the expert discussion:
- Why heart valve diseases remain among the greatest challenges facing modern medicine.
- Where existing therapies reach their limits and what consequences this has for patients and healthcare systems.
- How personalised medical technology enables new, potentially more sustainable treatment approaches.
- How EU funding programmes support the development and validation of this technology.
Find out how an innovative technology can transform cardiac surgery and discuss innovation, clinical application and the future of heart valve treatment live with leading experts.
Speaker:
Dr. med. Boris Schmitt ist Gründer von GrOwnValve und erfahrener Kardiologe mit über 20 Jahren klinischer und wissenschaftlicher Erfahrung, insbesondere in der Kinderkardiologie. Sein Fokus liegt auf der Behandlung angeborener Herzfehler und der Entwicklung neuer Therapieansätze. Aus seiner klinischen Erfahrung heraus verfolgt er das Ziel, Herzklappenbehandlungen nachhaltig zu verändern und wiederholte Eingriffe zu vermeiden.
Boris Warnack ist CTO von GrOwnValve und verfügt über mehr als 30 Jahre Erfahrung in der Medizintechnologie. In leitenden Positionen bei internationalen Healthcare-Unternehmen war er in der Entwicklung medizinischer Technologien tätig. Bei GrOwnValve bringt er seine Erfahrung ein, um die Technologie weiterzuentwickeln und in die klinische Anwendung zu überführen.
-
Location
-
Location
Online
Please select how you would like to register for the event:
Register per Email Registered participants
